regenera A natural breast for cancer survivors: resorbable implant supporting tissue regeneration
- Coordinator
- Tensive SRL, Italy
- Runs
- 1 March 2023 to 28 February 2025
- Status
- Finished
- EU funding
- €2.5m
- Total cost
- €3.6m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190163787
What the project is doing
In the project's own words, from its summary on CORDIS.
Of the 3 million women undergoing breast cancer resection every year, only a few opt for breast reconstruction due to pain, concerns about follow-up procedures and the lack of options. For lumpectomy patients traditional implants cannot be used, with only ~20-30% of lumpectomies being reconstructed. Autologous tissue transfer requires multiple painful interventions to reconstruct large volumes and obtain satisfactory results.
Furthermore, both implants and autologous solutions require multiple follow-up surgeries, increasing costs and pain for the patients. REGENERA will be a unique solution for lumpectomy patients: a resorbable implant designed to restore a natural breast through tissue self-regeneration. It is a cell-free porous scaffold made of resorbable biocompatible poly(urethane-ester-ether) with a biomimetic architecture. It is designed to avoid follow-up surgeries and eliminate the risks associated with silicone and saline implants (rupture, leakage, ALCL) and fat grafting.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Tensive SRL | Milano | Italy | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI